Roche Holding AG

Roche Holding AG is a Swiss multinational holding healthcare company headquartered in Basel, Switzerland, founded in 1896. It operates through two primary divisions: Pharmaceuticals and Diagnostics, positioning it as one of the world's largest biotech and pharmaceutical companies. The Pharmaceuticals division develops innovative medicines targeting major disease areas including oncology, where it leads globally, as well as cardio-metabolic diseases, diabetes, haematology, infectious diseases, inflammatory bowel diseases, neuroscience, ophthalmology, rare diseases, respiratory conditions, and women's health. The Diagnostics division produces equipment and reagents for research and medical applications, encompassing areas like applied science, professional diagnostics, diabetes care, molecular diagnostics, and tissue diagnostics through subsidiaries such as Ventana. Roche Holding AG integrates its strengths in pharmaceuticals and diagnostics to deliver transformative solutions that improve health outcomes and address pressing healthcare challenges. It owns key subsidiaries including the American biotechnology firm Genentech, Japanese Chugai Pharmaceuticals, and U.S.-based Ventana and Foundation Medicine, enhancing its global reach in biotech innovation.